Our Mission

Advancing the clinical translation
of regenerative medicine

P-CMRC groups carry out fundamental research of excellence aimed at solving outstanding bottlenecks
to the successful implementation of strategies of regenerative medicine

Featured News

The second RegenBell Symposium on stem cells and regenerative medicine takes place

After the good reception of the first edition in 2023, the second edition of the RegenBell Symposium was held this year on November 21 and 22.
The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject.
Throughout all Thursday and Friday morning, 11 conferences were presented, 9 of them by guest speakers, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

Read More »

Latest News

The second RegenBell Symposium on stem cells and regenerative medicine takes place

After the good reception of the first edition in 2023, the second edition of the RegenBell Symposium was held this year on November 21 and 22.
The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject.
Throughout all Thursday and Friday morning, 11 conferences were presented, 9 of them by guest speakers, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

Read More »

Dr. Meritxell Rovira, awarded with the “CRIS de Excelencia” Program to study pancreatic cancer

The scientist from P-CRM[C], IDIBELL and the University of Barcelona will lead a project aimed at identifying new early detection markers and developing personalized medicine strategies for this pathology.
The recognition granted by the CRIS Foundation against cancer aims to promote and consolidate the careers of researchers with an endowment of up to 1,250,000 euros.
In this call, grants totaling 11.4 million euros have been awarded to ensure that advances in research have a broader reach and impact the treatments received by patients.

Read More »

BST and IDIBELL generate a bank of stem cells that can be used as precursors for cell therapy

Scientists led by Dr Anna Veiga and Dr Sergi Querol have generated seven pluripotent stem cell lines from umbilical cord blood, compatible with 20% of the Spanish population.

These induced pluripotent stem cells (iPSCs) are created from adult cells from umbilical cord blood and can be used to produce advanced therapy drugs and test them in clinical trials, for example in retinal regeneration, heart, or immunotherapies.

Read More »

1st RegenBell symposium on Stem Cells and Regenerative Medicine

We are pleased to announce the First RegenBell symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans, downtown in Barcelona. The primary goal of the symposium is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.

Read More »

M Carolina Florian new ICREA Research Professor

Dra. M Carolina Florian, group leader at IDIBELL, has been appointed as an ICREA Research Professor. ICREA, the Catalan Institution for Research and Advanced Studies, offers permanent, tenured positions to the most talented and extraordinary scientists and academics to come and work in Catalonia. Over the years these positions have become a synonym for global academic excellence.

Read More »

The second RegenBell Symposium on stem cells and regenerative medicine takes place

After the good reception of the first edition in 2023, the second edition of the RegenBell Symposium was held this year on November 21 and 22.
The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject.
Throughout all Thursday and Friday morning, 11 conferences were presented, 9 of them by guest speakers, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

Read More »
Promoted by
With the support of
© P-CMRC 2009-2025– Legal NoticePrivacy Policy